| Accession |
PRJCA003976 |
| Title |
Potent Neutralizing Antibodies against SARS-CoV-2 |
| Relevance |
Medical |
| Data types |
Targeted Locus (Loci)
Transcriptome or Gene expression
|
| Organisms |
Homo sapiens
|
| Description |
The COVID-19 pandemic urgently needs therapeutic and prophylactic interventions. Here, we report the SARS-CoV-2-neutralizing antibodies identified by high-throughput single-cell RNA and VDJ sequencing of antigen-enriched B cells from 60 convalescent patients. |
| Sample scope |
Single cell |
| Release date |
2021-08-19 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| Ministry of Science and Technology of the People's Republic of China (MOST)
|
National Key Technologies R&D Program
|
2020YFC0848700
|
Potent Neutralizing Antibodies against SARS-CoV-2 Identification and Development
|
| the Beijing Municipal Commission of Science and Technology
|
|
Z201100005420018
|
|
| the Fundamental Research Funds for the Central Universities
|
|
A20ZX00846
|
|
|
|
| Submitter |
Xiaoliang
Sunney
Xie (datacontact@biopic.pku.edu.cn)
|
| Organization |
Peking University |
| Submission date |
2020-12-03 |
